Chromition

Manchester, United Kingdom Founded: 2014 • Age: 12 yrs
Nanoparticle-based solutions for displays and lighting are provided.
Request Access

About Chromition

Chromition is a company based in Manchester (United Kingdom) founded in 2014.. The company has 7 employees as of January 31, 2022. Chromition offers products and services including Luminspheres, DRACS, HER2 Detection, and CRISPR Detection. Chromition operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Manchester, United Kingdom
  • Employees 7 as on 31 Jan, 2022
  • Sectors
    Technology
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Chromition Limited
  • Date of Incorporation 28 Nov, 2014
  • Jurisdiction STOCKPORT, ENGLAND
Operational Areas
Technology → Semiconductors, Electronics & Hardware
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Quantum & Emerging Technologies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $55.67 K (USD), Grant

    May 31, 2019

  • Investors
    Mercia

    & 3 more

  • Employee Count
    7

    as on Jan 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Chromition

Chromition offers a comprehensive portfolio of products and services, including Luminspheres, DRACS, HER2 Detection, and CRISPR Detection. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Bright particles for simultaneous detection of multiple biological targets.

System for early cancer detection via blood sample analysis.

Ultra-sensitive method for identifying low-level HER2 in tissues.

Rapid tool for detecting target RNA at point of care.

Funding Insights of Chromition

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $55,670
  • First Round
  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2019 Amount Grant - Chromition Valuation

investors

Dec, 2018 Amount Grant - Chromition Valuation

investors

Nov, 2018 Amount Grant - Chromition Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Chromition

Chromition has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investment management services are provided by Mercia to various clients.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Chromition

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Chromition

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chromition Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Chromition

Chromition operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chromition

Frequently Asked Questions about Chromition

When was Chromition founded?

Chromition was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Chromition located?

Chromition is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.

How many employees does Chromition have?

As of Jan 31, 2022, the latest employee count at Chromition is 7.

What does Chromition do?

Chromition was founded in 2014 as a spin-out from the University of Manchester and is located in Manchester, United Kingdom. Nanoparticle technologies, including photoluminescent Luminspheres, semiconductor Elecspheres, and dielectric Dielecspheres, are developed for applications in bioimaging, anti-counterfeiting, lighting, detection, solar cells, sensors, and low-powered electronics. Patented Lumispheres particles are employed to bind with cancer cells for detection purposes.

Who are the top competitors of Chromition?

Chromition's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does Chromition offer?

Chromition offers Luminspheres, DRACS, HER2 Detection, and CRISPR Detection.

Who are Chromition's investors?

Chromition has 4 investors. Key investors include Mercia, European Union, EIC Fund, and SBRI Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available